Ryan Townley, MD
Neurology · Rochester, MNNPI 1689010399
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,760 of the $1,799 with a category attached, or 97.8%. Eisai Inc. accounts for 97.8% of it on its own, with 2 other manufacturers making up the rest.
Across 3 payments — averaging $599.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$2K
- Corium, LLC$25
- Hospira, Inc.$15
Across 97 payments — averaging $20,270 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$2M
- Novartis$196
What the payments were for
- Consulting fees$1,76098%
- Food & beverage$392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 1 | $1,760 |
| Corium, LLC | 1 | $25 |
| Hospira, Inc. | 1 | $15 |
How this compares
$1,799 in reported general payments places this provider in the 75th percentile of 434 neurology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 23 | $173,043 |
| Rivastigmine | 136 | $30,214 |
| Galantamine ErGalantamine Hbr | 257 | $24,743 |
| Donepezil Hcl | 1,299 | $13,089 |
| Aripiprazole | 17 | $5,010 |
| Memantine Hcl | 96 | $2,536 |
| Modafinil | 43 | $2,505 |
| Escitalopram Oxalate | 197 | $2,384 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 75 | $2,166 |
| Quetiapine Fumarate | 73 | $996 |
| Trazodone Hcl | 110 | $749 |
| Sertraline Hcl | 73 | $649 |
| Clonazepam | 30 | $205 |
Paid to pharmacies, not to this prescriber.
Other neurology in Rochester
- Alejandro RabinsteinRochester$305K
- Sean PittockRochester$231K
- Wolfgang SingerRochester$128K
- Ronald PetersenRochester$126K
- Partha GhoshRochester$121K
- Eoin FlanaganRochester$55K
- Keith CoffmanRochester$24K
- Igal MirmanRochester$18K
- P James DyckRochester$17K
- Suresh KotagalRochester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.